Sfoglia per Rivista GASTROENTEROLOGY
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease
2018-01-01 Danese, S; Bonovas, S; Lopez, A; Fiorino, G; Sandborn, Wj; Rubin, Dt; Kamm, Ma; Colombel, Jf; Sands, Be; Vermeire, S; Panes, J; Rogler, G; D'Haens, G; Peyrin-Biroulet, L
Impact of Artificial Intelligence on Miss Rate of Colorectal Neoplasia
2022-01-01 Wallace, Michael B.; Sharma, Prateek; Bhandari, Pradeep; East, James; Antonelli, Giulio; Lorenzetti, Roberto; Vieth, Micheal; Speranza, Ilaria; Spadaccini, Marco; Desai, Madhav; Lukens, Frank J.; Babameto, Genci; Batista, Daisy; Singh, Davinder; Palmer, William; Ramirez, Francisco; Palmer, Rebecca; Lunsford, Tisha; Ruff, Kevin; Bird-Liebermann, Elizabeth; Ciofoaia, Victor; Arndtz, Sophie; Cangemi, David; Puddick, Kirsty; Derfus, Gregory; Johal, Amitpal S.; Barawi, Mohammed; Longo, Luigi; Moro, Luigi; Repici, Alessandro; Hassan, Cesare
Impact of Image Enhanced Endoscopy Using Electronic Chromoendoscopy on Adenoma Miss Rates During Colonoscopy: A Systematic Review and Meta-Analysis
2016-01-01 Desai, M; Gupta, N; Choudhary, A; Vennalaganti, P; Vennelaganti, S; Sferrazza, S; Repici, A; Hassan, C; Sharma, P
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study
2012-01-01 Fiorino, G; Biroulet, L; Naccarato, P; De Cassan, C; Bonifacio, C; Sociale, O; Balzarini, L; Repici, A; Malesci, A; Danese, S
Impact of Tumour Necrosis Factor Antagonists on Avoiding Surgery in Stricturing Crohn's Disease: A Tertiary Center Real-Life Experience
2016-01-01 Allocca, M; Fiorino, G; Bonifacio, C; Spinelli, A; Repici, A; Malesci, A; Balzarini, L; Danese, S
In the Presence of Conceptual Heterogeneity, Results of Network Meta-analysis Comparing Therapies in Crohn's Disease Need to Be Interpreted With Caution
2015-01-01 Bonovas, S; Moja, L; Danese, S
In Vivo and In Vitro Immune Response to Pandemic Influenza 2009 H1N1 Vaccine in Inflammatory Bowel Disease Patients on Anti TNF-Alpha Treatment
2011-01-01 Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; De Vitis, I; Rapaccini, Gl; Guidi, L
Inactivated Lactobacillus acidophilus increases the efficacy of a standard anti-H-pylori antibiotic therapy
2000-01-01 Canducci, F; Armuzzi, A; Gasbarrini, Gb; Gasbarrini, A
Incidence and symptoms related to Helicobacter pylori infection in dyspeptic patients
1997-01-01 Gasbarrini, A; Deluca, A; Ojetti, V; Franceschi, F; Candelli, M; Dicampli, C; Armuzzi, A; Anti, M; Fedeli, G; Pola, P; Gasbarrini, G
Incidence and symptoms related to Helicobacter pylori infection in patients with headache
1997-01-01 Deluca, A; Gasbarrini, A; Fiore, G; Ojetti, V; Franceschi, F; Dicampli, C; Candelli, M; Armuzzi, A; Anti, M; Pola, P; Giacovazzo, M; Gasbarrini, G
INCREASING ADENOMA DETECTION RATE (ADR) IN THE RIGHT COLON - WHICH TECHNIQUE IS BETTER: RETRO-FLEXION OR A SECOND FORWARD LOOK: A SYSTEMATIC REVIEW OF THE PUBLISHED LITERATURE
2018-01-01 Desai, M; Hamade, N; Bilal, M; Gorrepati, Vs; Chandrasekar, Vt; Jegadeesan, R; Gupta, N; Bhandari, P; Repici, A; Hassan, C; Sharma, P
Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization
2020-01-01 D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent
Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy
2020-01-01 D'Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio
Infliximab Discontinuation Is Associated With a Higher Risk for Relapse in Patients With Ulcerative Colitis in Remission: A Multinational Collaborative Retrospective Study
2016-01-01 Fiorino, G; Ellul, P; Muscat, M; Karatzas, P; Silva, M; Peixoto, A; Felice, C; Bossa, F; Lakatos, Pl; Sebastian, S; Ungar, B; Furfaro, F; Karmiris, K; Katsanos, K; Navarro, P; Bosca-Watts, Mm; Christodoulou, Dk; Maconi, G; Kopylov, U; Armuzzi, A; Magro, F; Mantzaris, Gj; Ben-Horin, S; Danese, S
Infliximab in Steroid-Dependent Ulcerative Colitis
2011-01-01 Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; Vitale, G; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L
Infliximab in Steroid-Dependent Ulcerative Colitis: Efficacy and Predictors of Clinical and Endoscopic Remission
2012-01-01 Armuzzi, A; Pugliese, D; Danese, S; Rizzo, G; Felice, C; Marzo, M; Andrisani, G; Fiorino, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L
Infliximab in the treatment of glucocorticoid-dependent ulcerative colitis: a 54 week randomized methylprednisolone-controlled trial
2005-01-01 Armuzzi, A; Lupascu, A; De Pascalis, B; Fedeli, P; Vincenti, F; Girsbarrini, G; Gasbarrini, A
Infliximab in the treatment of moderate to severe glucocorticoid dependent ulcerative colitis: A randomized methylprednisolone controlled trial
2004-01-01 Armuzzi, A; Lupascu, A; Fedeli, P; De Pascalis, B; Gasbarriini, G; Gasbarrini, A
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease
2009-01-01 Danese, S; Fiorino, G; Vetrano, S; Rando, G; Pagano, N; Romeo, F; Omodei, P; Repici, A; Rutella, S; Malesci, A
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection
2016-01-01 Regueiro, M; Feagan, Bg; Zou, B; Johanns, J; Blank, Ma; Chevrier, M; Plevy, S; Popp, J; Cornillie, Fj; Lukas, M; Danese, S; Gionchetti, P; Hanauer, Sb; Reinisch, W; Sandborn, Wj; Sorrentino, D; Rutgeerts, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease | 1-gen-2018 | Danese, S; Bonovas, S; Lopez, A; Fiorino, G; Sandborn, Wj; Rubin, Dt; Kamm, Ma; Colombel, Jf; Sands, Be; Vermeire, S; Panes, J; Rogler, G; D'Haens, G; Peyrin-Biroulet, L | |
Impact of Artificial Intelligence on Miss Rate of Colorectal Neoplasia | 1-gen-2022 | Wallace, Michael B.; Sharma, Prateek; Bhandari, Pradeep; East, James; Antonelli, Giulio; Lorenzetti, Roberto; Vieth, Micheal; Speranza, Ilaria; Spadaccini, Marco; Desai, Madhav; Lukens, Frank J.; Babameto, Genci; Batista, Daisy; Singh, Davinder; Palmer, William; Ramirez, Francisco; Palmer, Rebecca; Lunsford, Tisha; Ruff, Kevin; Bird-Liebermann, Elizabeth; Ciofoaia, Victor; Arndtz, Sophie; Cangemi, David; Puddick, Kirsty; Derfus, Gregory; Johal, Amitpal S.; Barawi, Mohammed; Longo, Luigi; Moro, Luigi; Repici, Alessandro; Hassan, Cesare | |
Impact of Image Enhanced Endoscopy Using Electronic Chromoendoscopy on Adenoma Miss Rates During Colonoscopy: A Systematic Review and Meta-Analysis | 1-gen-2016 | Desai, M; Gupta, N; Choudhary, A; Vennalaganti, P; Vennelaganti, S; Sferrazza, S; Repici, A; Hassan, C; Sharma, P | |
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study | 1-gen-2012 | Fiorino, G; Biroulet, L; Naccarato, P; De Cassan, C; Bonifacio, C; Sociale, O; Balzarini, L; Repici, A; Malesci, A; Danese, S | |
Impact of Tumour Necrosis Factor Antagonists on Avoiding Surgery in Stricturing Crohn's Disease: A Tertiary Center Real-Life Experience | 1-gen-2016 | Allocca, M; Fiorino, G; Bonifacio, C; Spinelli, A; Repici, A; Malesci, A; Balzarini, L; Danese, S | |
In the Presence of Conceptual Heterogeneity, Results of Network Meta-analysis Comparing Therapies in Crohn's Disease Need to Be Interpreted With Caution | 1-gen-2015 | Bonovas, S; Moja, L; Danese, S | |
In Vivo and In Vitro Immune Response to Pandemic Influenza 2009 H1N1 Vaccine in Inflammatory Bowel Disease Patients on Anti TNF-Alpha Treatment | 1-gen-2011 | Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; De Vitis, I; Rapaccini, Gl; Guidi, L | |
Inactivated Lactobacillus acidophilus increases the efficacy of a standard anti-H-pylori antibiotic therapy | 1-gen-2000 | Canducci, F; Armuzzi, A; Gasbarrini, Gb; Gasbarrini, A | |
Incidence and symptoms related to Helicobacter pylori infection in dyspeptic patients | 1-gen-1997 | Gasbarrini, A; Deluca, A; Ojetti, V; Franceschi, F; Candelli, M; Dicampli, C; Armuzzi, A; Anti, M; Fedeli, G; Pola, P; Gasbarrini, G | |
Incidence and symptoms related to Helicobacter pylori infection in patients with headache | 1-gen-1997 | Deluca, A; Gasbarrini, A; Fiore, G; Ojetti, V; Franceschi, F; Dicampli, C; Candelli, M; Armuzzi, A; Anti, M; Pola, P; Giacovazzo, M; Gasbarrini, G | |
INCREASING ADENOMA DETECTION RATE (ADR) IN THE RIGHT COLON - WHICH TECHNIQUE IS BETTER: RETRO-FLEXION OR A SECOND FORWARD LOOK: A SYSTEMATIC REVIEW OF THE PUBLISHED LITERATURE | 1-gen-2018 | Desai, M; Hamade, N; Bilal, M; Gorrepati, Vs; Chandrasekar, Vt; Jegadeesan, R; Gupta, N; Bhandari, P; Repici, A; Hassan, C; Sharma, P | |
Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization | 1-gen-2020 | D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent | |
Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy | 1-gen-2020 | D'Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio | |
Infliximab Discontinuation Is Associated With a Higher Risk for Relapse in Patients With Ulcerative Colitis in Remission: A Multinational Collaborative Retrospective Study | 1-gen-2016 | Fiorino, G; Ellul, P; Muscat, M; Karatzas, P; Silva, M; Peixoto, A; Felice, C; Bossa, F; Lakatos, Pl; Sebastian, S; Ungar, B; Furfaro, F; Karmiris, K; Katsanos, K; Navarro, P; Bosca-Watts, Mm; Christodoulou, Dk; Maconi, G; Kopylov, U; Armuzzi, A; Magro, F; Mantzaris, Gj; Ben-Horin, S; Danese, S | |
Infliximab in Steroid-Dependent Ulcerative Colitis | 1-gen-2011 | Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; Vitale, G; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L | |
Infliximab in Steroid-Dependent Ulcerative Colitis: Efficacy and Predictors of Clinical and Endoscopic Remission | 1-gen-2012 | Armuzzi, A; Pugliese, D; Danese, S; Rizzo, G; Felice, C; Marzo, M; Andrisani, G; Fiorino, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L | |
Infliximab in the treatment of glucocorticoid-dependent ulcerative colitis: a 54 week randomized methylprednisolone-controlled trial | 1-gen-2005 | Armuzzi, A; Lupascu, A; De Pascalis, B; Fedeli, P; Vincenti, F; Girsbarrini, G; Gasbarrini, A | |
Infliximab in the treatment of moderate to severe glucocorticoid dependent ulcerative colitis: A randomized methylprednisolone controlled trial | 1-gen-2004 | Armuzzi, A; Lupascu, A; Fedeli, P; De Pascalis, B; Gasbarriini, G; Gasbarrini, A | |
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease | 1-gen-2009 | Danese, S; Fiorino, G; Vetrano, S; Rando, G; Pagano, N; Romeo, F; Omodei, P; Repici, A; Rutella, S; Malesci, A | |
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection | 1-gen-2016 | Regueiro, M; Feagan, Bg; Zou, B; Johanns, J; Blank, Ma; Chevrier, M; Plevy, S; Popp, J; Cornillie, Fj; Lukas, M; Danese, S; Gionchetti, P; Hanauer, Sb; Reinisch, W; Sandborn, Wj; Sorrentino, D; Rutgeerts, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile